Unicentric Castleman Disease: Diagnosis, Treatment, and Specialist Access
Unicentric Castleman disease involves enlargement of a single lymph node region and is generally considered curable with complete surgical removal, though accurate diagnosis requires distinguishing it from lymphoma and other conditions.
- Often Curable With Surgery
- Specialist Pathology Review
- Second Opinion Coordination
- Most Common In
- Adults in their 20sā40s
- Disease Pattern
- Single Enlarged Lymph Node Region
- Key Diagnostic Tool
- Excisional Lymph Node Biopsy
- Standard Treatment
- Complete Surgical Excision
Condition Overview
Unicentric Castleman disease is a rare lymphoproliferative disorder in which a single lymph node or lymph node region becomes enlarged due to abnormal lymph node architecture, rather than infection or malignancy. It is the localized form of Castleman disease, distinct from the multicentric form, which affects multiple lymph node regions throughout the body.
Most people with unicentric Castleman disease are not infected with human herpesvirus-8 (HHV-8), which is the driver of many multicentric cases. The condition is often discovered incidentally on imaging or when a person notices a slowly enlarging mass.
Because the enlarged lymph node can resemble lymphoma on imaging, accurate diagnosis through excisional biopsy and expert pathology review is essential. Complete surgical removal of the affected lymph node is usually curative.
Types and Subtypes
Unicentric Castleman disease is classified by the pathologic pattern seen under the microscope, which can influence symptoms and presentation.
Symptoms and Signs
Many people with unicentric Castleman disease have no symptoms beyond the enlarged lymph node itself, which is often found incidentally.
Causes and Risk Factors
The exact cause of unicentric Castleman disease is not fully understood, and most cases occur without identifiable risk factors.
Diagnosis and Investigations
Diagnosis requires a full excisional biopsy of the affected lymph node, since needle biopsies often cannot reliably distinguish Castleman disease from lymphoma.
Staging and Risk Groups
Unicentric Castleman disease does not use a traditional cancer staging system. Instead, classification focuses on confirming disease is limited to a single lymph node region and assessing for any associated systemic features.
Standard Treatment Options
Complete surgical removal of the affected lymph node is the standard and usually curative treatment for unicentric Castleman disease.
Advanced & Emerging Therapies
Advanced therapies are rarely needed for unicentric disease but may be considered when surgery is not possible.
Targeted Therapy
IL-6 Pathway Inhibitors
Primarily used in multicentric Castleman disease, but may be considered for unresectable unicentric cases to shrink the mass.
Radiation
Radiation Therapy
An option for unresectable unicentric disease or when surgery carries high risk due to location.
Biomarkers & Precision Medicine
Laboratory markers help confirm diagnosis and monitor for systemic involvement in Castleman disease.
When a Second Opinion May Be Important
Because Castleman disease can resemble other conditions, specialist review is valuable in several situations.
Clinical Trials and Research
Prognosis & Outcomes
Unicentric Castleman disease generally carries an excellent long-term outlook once the affected lymph node is completely removed.
Supportive Care and Living With Unicentric Castleman Disease
Most people recover fully after surgical treatment, though some supportive measures can help during diagnosis and recovery.
How CancerFax Helps You Explore Treatment Options
CancerFax helps patients with Castleman disease get pathology and imaging reports reviewed by specialists, coordinate second opinions, and connect with surgeons experienced in lymph node excision for difficult-to-access disease.
Get a free case reviewFrequently Asked Questions
Unicentric Castleman disease is a rare condition in which a single lymph node region becomes enlarged due to abnormal lymph node architecture, rather than infection or cancer. It is generally curable with surgical removal.
Unicentric Castleman disease is not a cancer, though it involves abnormal lymph node growth that can resemble lymphoma on imaging and requires careful diagnosis to distinguish the two.
Unicentric disease involves only one lymph node region and is usually cured with surgery, while multicentric disease affects multiple lymph node regions throughout the body and typically requires ongoing systemic treatment.
Many people have no symptoms beyond a slowly enlarging, painless lump. Some people experience mild fatigue or intermittent low-grade fevers.
A needle biopsy often cannot capture enough lymph node architecture to reliably distinguish Castleman disease from lymphoma, so complete excisional biopsy is generally recommended.
Yes, in the large majority of cases, complete surgical removal of the affected lymph node region is curative.
If surgery is not feasible due to location, radiation therapy or medical therapy targeting the IL-6 pathway may be considered to manage the disease.
Recurrence is uncommon after complete surgical removal, though periodic follow-up is still recommended.
HHV-8 is a virus linked to many cases of multicentric Castleman disease. Most unicentric cases are HHV-8 negative, which helps confirm the diagnosis as the more localized, surgically curable form.
Yes. CancerFax can help you get your lymph node biopsy and imaging reports reviewed by specialists, coordinate a second opinion, and connect with experienced surgeons for lymph node regions that are difficult to access, including coordination with international centers where relevant.
Get Expert Guidance on Your Castleman Disease Diagnosis
Send your lymph node biopsy and imaging reports to CancerFax for specialist review.